Suppr超能文献

作为抗癌剂的微管相互作用天然产物。

Tubulin-interactive natural products as anticancer agents.

机构信息

Department of Chemistry, M/C 0212, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0212, USA.

出版信息

J Nat Prod. 2009 Mar 27;72(3):507-15. doi: 10.1021/np800568j.

Abstract

This review provides an overview of the discovery, structures, and biological activities of anticancer natural products that act by inhibiting or promoting the assembly of tubulin to microtubules. The emphasis is on providing recent information on those compounds in clinical use or in advanced clinical trials. The vinca alkaloids, the combretastatins, NPI-2358, the halichondrin B analogue eribulin, dolastatin 10, noscapine, hemiasterlin, and rhizoxin are discussed as tubulin polymerization inhibitors, while the taxanes and the epothilones are the major classes of tubulin polymerization promoters presented, with brief treatments of discodermolide, eleutherobin, and laulimalide. The challenges and future directions of tubulin-interactive natural products-based drug discovery programs are also discussed briefly.

摘要

这篇综述概述了通过抑制或促进微管蛋白组装来发挥作用的抗癌天然产物的发现、结构和生物活性。重点是提供那些在临床使用或在临床试验中处于先进阶段的化合物的最新信息。长春碱类生物碱、考布他汀类、NPI-2358、海兔内酯类似物埃博霉素、多紫杉醇 10、石蒜碱、海兔内酯和瑞香毒素被讨论为微管蛋白聚合抑制剂,而紫杉醇类和埃坡霉素类则是主要的微管蛋白聚合促进剂类别,简要讨论了 discodermolide、eleutherobin 和 laulimalide。还简要讨论了基于微管蛋白相互作用的天然产物药物发现计划的挑战和未来方向。

相似文献

1
Tubulin-interactive natural products as anticancer agents.
J Nat Prod. 2009 Mar 27;72(3):507-15. doi: 10.1021/np800568j.
2
Natural products as antimitotic agents.
Curr Top Med Chem. 2014;14(20):2272-85. doi: 10.2174/1568026614666141130095311.
4
Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site.
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9). doi: 10.1073/pnas.2021847118.
5
Antimicrotubular drugs binding to vinca domain of tubulin.
Mol Cell Biochem. 2003 Nov;253(1-2):41-7. doi: 10.1023/a:1026045100219.
6
Mechanism of action of antitumor drugs that interact with microtubules and tubulin.
Curr Med Chem Anticancer Agents. 2002 Jan;2(1):1-17. doi: 10.2174/1568011023354290.
7
Towards modern anticancer agents that interact with tubulin.
Eur J Pharm Sci. 2019 Apr 1;131:58-68. doi: 10.1016/j.ejps.2019.01.028. Epub 2019 Jan 25.
9
Anticancer therapy with novel tubulin-interacting drugs.
Drug Resist Updat. 2001 Dec;4(6):392-401. doi: 10.1054/drup.2002.0230.

引用本文的文献

2
Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy.
Biologics. 2024 Sep 10;18:229-255. doi: 10.2147/BTT.S484068. eCollection 2024.
3
Natural Anticancer Peptides from Marine Animal Species: Evidence from In Vitro Cell Model Systems.
Cancers (Basel). 2023 Dec 20;16(1):36. doi: 10.3390/cancers16010036.
4
Disturbing cytoskeleton by engineered nanomaterials for enhanced cancer therapeutics.
Bioact Mater. 2023 Jun 29;29:50-71. doi: 10.1016/j.bioactmat.2023.06.016. eCollection 2023 Nov.
5
Crosstalk between Microtubule Stabilizing Agents and Prostate Cancer.
Cancers (Basel). 2023 Jun 23;15(13):3308. doi: 10.3390/cancers15133308.
6
Effect of the Marine Polyketide Plocabulin on Tumor Progression.
Mar Drugs. 2022 Dec 31;21(1):38. doi: 10.3390/md21010038.
7
Integrated analysis reveals effects of bioactive ingredients from (Girard) Kuntze on hypoxia-inducible factor (HIF) activation.
Front Plant Sci. 2022 Oct 27;13:994036. doi: 10.3389/fpls.2022.994036. eCollection 2022.
8
Synthesis and antitumor activity of litseaone B analogues as tubulin polymerisation inhibitors.
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2530-2539. doi: 10.1080/14756366.2022.2122962.
10
Cytotoxicity of phenylpironetin analogs and the metabolic fate of pironetin and phenylpironetin.
Bioorg Chem. 2022 Aug;125:105915. doi: 10.1016/j.bioorg.2022.105915. Epub 2022 May 27.

本文引用的文献

1
(+)-Discodermolide: Total Synthesis, Construction of Novel Analogues, and Biological Evaluation.
Tetrahedron. 2007 Jan 7;64(2):261-298. doi: 10.1016/j.tet.2007.10.039.
2
Sagopilone (ZK-EPO): from a natural product to a fully synthetic clinical development candidate.
Expert Opin Investig Drugs. 2008 Nov;17(11):1735-48. doi: 10.1517/13543784.17.11.1735.
3
Clinical status of anti-cancer agents derived from marine sources.
Anticancer Agents Med Chem. 2008 Aug;8(6):603-17.
4
Natural products to drugs: natural product-derived compounds in clinical trials.
Nat Prod Rep. 2008 Jun;25(3):475-516. doi: 10.1039/b514294f. Epub 2008 May 7.
5
Protein nanoparticles as drug carriers in clinical medicine.
Adv Drug Deliv Rev. 2008 May 22;60(8):876-85. doi: 10.1016/j.addr.2007.08.044. Epub 2008 Feb 7.
7
Epothilones and new analogues of the microtubule modulators in taxane-resistant disease.
Expert Opin Investig Drugs. 2008 Apr;17(4):523-46. doi: 10.1517/13543784.17.4.523.
8
Antitumor activity of noscapine in human non-small cell lung cancer xenograft model.
Cancer Chemother Pharmacol. 2008 Dec;63(1):117-26. doi: 10.1007/s00280-008-0720-z. Epub 2008 Mar 13.
9
The structure activity relationship of discodermolide analogues.
Mini Rev Med Chem. 2008 Mar;8(3):276-84. doi: 10.2174/138955708783744137.
10
New taxanes in development.
Expert Opin Investig Drugs. 2008 Mar;17(3):335-47. doi: 10.1517/13543784.17.3.335.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验